60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.87 -0.02 (-2.10%)
As of: Oct 22, 2026 · 11:47 AM EDT

60 Degrees Pharmaceuticals (SXTP) Long-Term Debt Issuances (2023)

Updated

60 Degrees Pharmaceuticals (SXTP) reported Long-Term Debt Issuances of $650,000 for FY2023, down 18.8% from $800,000 in FY2022.

Analysis

60 Degrees Pharmaceuticals (SXTP) Long-Term Debt Issuances (2023) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Issuances came in at $800,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn -
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn -
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn -
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn -
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn -
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 60 Degrees Pharmaceuticals 2.36 Mn 1.34 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 700,000.00
Mar 31, 2023 200,000.00
API Access

60 Degrees Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SXTP&period=max&api_key=YOUR_API_KEY